Jenson Healthcare Profile
Key Indicators
- Authorised Capital ₹ 7.00 M
as on 12-07-2024
- Paid Up Capital ₹ 6.54 M
as on 12-07-2024
- Company Age 37 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -5.21%
(FY 2020)
- Profit -8336.47%
(FY 2020)
- Ebitda -566.70%
(FY 2020)
- Net Worth -1.47%
(FY 2020)
- Total Assets -1.37%
(FY 2020)
About Jenson Healthcare
The Corporate was formerly known as Jenson Healthcare Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.00 M and a paid-up capital of Rs 6.54 M, as per Ministry of Corporate Affairs (MCA) records.
Tanya Jain and Sakshi Jain serve as directors at the Company.
- CIN/LLPIN
U74999UP1987PTC072332
- Company No.
072332
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Mar 1987
- Date of AGM
26 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jenson Healthcare?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Tanya Jain | Additional Director | Current | |
Sakshi Jain | Director | 09-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Jenson Healthcare.
Jenson Healthcare Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 5.21% decrease. The company also saw a substantial fall in profitability, with a 8336.47% decrease in profit. The company's net worth dipped by a decrease of 1.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Jenson Healthcare?
In 2020, Jenson Healthcare had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rajhans Enterprises Private LimitedActive 11 years 11 months
Tanya Jain and Sakshi Jain are mutual person
- Cosy Pharmaceuticals Private LimitedActive 38 years 10 months
Tanya Jain and Sakshi Jain are mutual person
- Shivangi Remedies Private LimitedActive 28 years 5 months
Tanya Jain and Sakshi Jain are mutual person
- Shivangi Credits Private LimitedActive 28 years 3 months
Tanya Jain and Sakshi Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jenson Healthcare?
Unlock and access historical data on people associated with Jenson Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jenson Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jenson Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.